linked in, page-2

"Madaus had been CEO of Millipore from 2005 until mid-2010, when the company was acquired by German pharmaceutical firm Merck KGaA for $7.2 billion. Before that he had been CEO of Roche Diagnostics."

Dr Geoff Cumming has over 20 years experience in the healthcare and biotechnology industries. Geoff's roles have progressed from research to sales and marketing roles to Managing Director level and Board seats. Previously he served as Managing Director of Roche Diagnostic Systems - Oceania Regional Centre, where he transformed a loss making business to one achieving over 30% compound annual growth over a four year period and the highest profitability levels in Roche's global organisation.

The plot thickens................